What Is Atopic Dermatitis? Symptoms, Causes & Treatment

Atopic dermatitis is a chronic inflammatory skin condition marked by intense itching, dry skin, and recurring patches of red or inflamed skin that can crack, weep, and thicken over time. It is the most common form of eczema, driven by a combination of a leaky skin barrier, an overactive immune response, and environmental triggers. While it often begins in infancy, it can persist into adulthood or even appear for the first time in adults, and its effects reach well beyond the skin itself.

How Atopic Dermatitis Looks and Feels at Different Ages

The hallmark symptom is itch, often severe enough to disrupt sleep and daily life. But the appearance of the rash shifts depending on when it shows up. In infants under two, the skin tends to develop itchy, weepy patches on the face, trunk, and outer surfaces of the arms and legs. The redness is often poorly defined, and crusting is common. In older children, the pattern shifts toward drier, thicker patches concentrated in the creases of the elbows and knees, on the hands and feet, and sometimes around the mouth and eyes. Adolescents and adults typically present with symmetrical thickened plaques, along with scratch marks from chronic rubbing.

¹

People who develop atopic dermatitis for the first time as adults tend to look somewhat different from those who have carried it since childhood. Adult-onset cases are more likely to feature coin-shaped (nummular) lesions and less likely to involve the classic signs like eyelid inflammation, scalp involvement, or the deep creases under the eyes known as Dennie-Morgan folds. They also tend to have fewer total signs and symptoms overall.

²

What Is Going Wrong in the Skin

Two major problems work together to produce atopic dermatitis: a compromised skin barrier and an immune system that overreacts. A protein called filaggrin plays a central role in the first problem. Filaggrin helps build the outermost layer of skin by binding structural filaments together and, when it breaks down, produces natural moisturizing compounds that keep the skin hydrated. When filaggrin is deficient or dysfunctional, the skin dries out more easily and loses its ability to keep irritants, allergens, and microbes from penetrating inward.

³

Once those foreign substances slip through the weakened barrier, the immune system kicks into overdrive. The inflammatory response in atopic dermatitis is dominated by a branch of immunity that produces signaling molecules called interleukin-4 and interleukin-13. These molecules drive the redness, swelling, and thickening of the skin that define the condition.

⁴ Interleukin-13 in particular is overproduced in the inflamed skin of people with atopic dermatitis and acts as a central driver of the ongoing inflammation.⁵

The immune picture is not identical in everyone. In young children whose atopic dermatitis has just appeared, a broader set of immune pathways are activated compared with adults who have had the disease for years. This may partly explain why the condition looks and behaves differently in children versus adults, and why treatments don’t always work the same way across age groups.

⁶

Why the Itch Is So Intense

The itch of atopic dermatitis is not just ordinary dry-skin itch. Multiple mediators contribute to it, including substances like interleukin-31, serine proteases, and nerve growth factor, all of which can activate or sensitize the nerve fibers in the skin. Both the skin itself and the central nervous system are involved: inflamed skin sends more itch signals, and over time the brain can become more sensitive to those signals, amplifying the sensation.

⁷

This is why people with atopic dermatitis often describe the itch as unbearable, especially at night. It triggers a scratch-itch cycle: scratching damages the skin further, which provokes more inflammation, which produces more itch. Breaking that cycle is one of the primary goals of treatment.

Genetics, Family History, and the Filaggrin Connection

Atopic dermatitis runs in families. It shows high heritability, meaning that genetics account for a substantial share of who develops it. The single strongest genetic risk factor identified so far is loss-of-function mutations in the gene that encodes filaggrin. But filaggrin mutations alone don’t explain the whole picture. Genetic variants affecting how the immune system functions also play a role, and the condition arises from the interplay of multiple genetic and environmental factors rather than from any single gene.

⁸

This helps explain a pattern many families notice: one child has atopic dermatitis while a sibling does not, even though they share the same parents and the same home. Carrying a filaggrin mutation increases risk but does not guarantee the condition. And many people with atopic dermatitis have no identifiable filaggrin mutation at all, underscoring that other pathways are at work.

People with adult-onset atopic dermatitis tend to have weaker family histories of the condition compared with those whose disease started in childhood. They are also less likely to have a personal history of asthma, hay fever, or food allergy.

²

Environmental Triggers and the Urban Factor

The worldwide rise in atopic dermatitis over recent decades can’t be pinned on genetics alone, because genes don’t change that fast across populations. Environmental exposures, from household allergens and air pollution to climate conditions, are well-recognized triggers that can set off or worsen flares in people who are already predisposed.

⁹¹⁰

Common triggers include dust mites, pet dander, pollen, dry or cold weather, harsh soaps and detergents, wool fabrics, and emotional stress. Many people with atopic dermatitis learn their own personal trigger profile over time, which can be helpful for avoidance strategies even if it doesn’t eliminate flares entirely.

Where you live matters too. A systematic review and meta-analysis found that living in an urban area was associated with roughly a 55% higher risk of atopic dermatitis compared with rural living, with the effect particularly strong in children. The gap was wider in developing countries than in developed ones, and it has been growing in recent decades.

¹¹ Lower socioeconomic status, linked to poorer living conditions and limited healthcare access, has also been identified as a risk factor in both urban and rural settings.¹²

The so-called “hygiene hypothesis” is often invoked to explain some of these patterns. The idea is that reduced exposure to certain microbes early in life may predispose the immune system toward allergic responses. There is some prospective evidence supporting an inverse relationship between atopic dermatitis and early exposure to things like endotoxins, day care, and animals.

¹³

Skin Bacteria and Flares

Healthy skin hosts a diverse community of microorganisms. In people with atopic dermatitis, that diversity drops, and a particular bacterium, Staphylococcus aureus, tends to take over. This imbalance is present even between flares and becomes more pronounced as the disease worsens.

¹⁴

The relationship between S. aureus and atopic dermatitis is not just a bystander effect. Certain strains produce virulence factors that can directly trigger flares. In mouse experiments, these specific strains induced skin inflammation resembling atopic dermatitis, suggesting that the bacterium is not merely colonizing damaged skin but actively making the disease worse.

¹⁵

This is one reason dermatologists sometimes prescribe short courses of dilute bleach baths or antiseptic washes as part of a management plan: the goal is to reduce S. aureus colonization and break the cycle of bacterial overgrowth and inflammation.

The Atopic March

Atopic dermatitis in infancy is often the first step in a progression called the atopic march. The sequence typically goes from atopic dermatitis to food allergy, then to allergic rhinitis (hay fever), and finally to asthma. About one-third of children with atopic dermatitis go on to develop asthma, and a similar proportion develop allergic rhinitis. Early-onset and severe atopic dermatitis is linked to a significantly higher risk of developing these other allergic conditions.

¹⁶

Not every child with atopic dermatitis follows the march. Many outgrow the skin disease without ever developing asthma or significant allergies. But the risk is real enough that pediatricians often monitor children with moderate-to-severe atopic dermatitis more closely for signs of emerging respiratory or food allergies.

Sleep, Mental Health, and Quality of Life

The impact of atopic dermatitis extends well beyond the skin. Sleep disruption is one of the most burdensome consequences, and it’s not simply a matter of itch keeping you awake. Research now indicates that the sleep disturbance in atopic dermatitis is a complex feature of the disease itself, associated with higher inflammatory activity, fragmented sleep architecture, daytime fatigue, and increased risk of anxiety and depression.

¹⁷

The psychological toll is considerable. Long-term, poorly controlled itch can lead to irritability, frustration, social withdrawal, and depressive symptoms. Because the disease is visible and often affects the face and hands, it can carry social stigma as well. For children, the combination of disrupted sleep and chronic discomfort can affect school performance and social development.

¹⁸

Treatment Options

Managing atopic dermatitis almost always starts with daily skincare. Regular use of moisturizers (emollients) to repair and protect the barrier is the foundation of treatment regardless of disease severity. Beyond that, therapy is generally tiered based on how severe the disease is and how well it responds to initial measures.

Topical Treatments

Topical corticosteroids remain the first-line treatment for flares. They are effective anti-inflammatory agents available in a wide range of strengths, but long-term or high-potency use raises concerns about skin thinning and other side effects. For sensitive areas like the face and skin folds, or for longer-term maintenance, topical calcineurin inhibitors such as tacrolimus and pimecrolimus offer an alternative anti-inflammatory pathway without the skin-thinning risk. These are generally positioned as second-line options.

¹⁹

A newer option, crisaborole, works through a different mechanism entirely by inhibiting an enzyme called phosphodiesterase 4. It has a milder safety profile and is used primarily for mild-to-moderate disease. For severe flares in children, a technique called wet-wrap therapy, in which damp bandages are applied over a layer of diluted corticosteroid or emollient, can bring faster improvement. A randomized trial found that wet wraps with diluted corticosteroids worked faster and more effectively than wet wraps with emollients alone, with significant differences in disease severity scores and quality of life.

¹⁹²⁰

Systemic and Biologic Therapies

When topical treatments are not enough, systemic therapies come into play. The landscape here has changed dramatically in recent years. Biologic drugs like dupilumab block interleukin-4 and interleukin-13, the key inflammatory signals described earlier, while tralokinumab targets interleukin-13 specifically, and nemolizumab targets interleukin-31, which is more directly involved in itch. These biologics are highly targeted, meaning they shut down a narrow set of pathways while leaving much of the immune system intact.

A different class, JAK inhibitors, works by blocking enzymes inside cells that transmit signals from a broader range of inflammatory molecules. This gives them a wider reach than biologics but also means they can have more diverse effects, both therapeutic and otherwise.

²¹

Phototherapy

Ultraviolet light therapy, especially narrowband UVB, is another option for moderate-to-severe disease that hasn’t responded adequately to topical treatment. It works by dampening immune activity in the skin and is considered both effective and generally safe. It does require regular clinic visits, typically two to three times per week, which can be a practical barrier for many people.

²²

Diet, Supplements, and Common Misconceptions

Many parents and patients turn to dietary changes hoping to control atopic dermatitis. The evidence, however, is discouraging for most popular dietary strategies. Restricting the mother’s diet during pregnancy or breastfeeding, using hydrolyzed infant formulas, delaying the introduction of solid foods, and supplementing with omega-3 or omega-6 fatty acids have all been studied, and none appear to have a meaningful effect on preventing or treating the condition.

²³

That said, some individuals with confirmed food allergies (diagnosed by proper testing, not just suspicion) may see improvement when trigger foods are eliminated. The key distinction is between a true, tested food allergy and a vague sense that certain foods “make the eczema worse.” Unnecessary dietary restrictions, especially in children, risk nutritional deficiencies without meaningful skin improvement. If you suspect a food trigger, work with an allergist rather than eliminating foods on your own.

Conditions That Can Mimic Atopic Dermatitis

Atopic dermatitis is diagnosed clinically, meaning there is no single lab test that confirms it. Doctors look for a characteristic pattern of symptoms, distribution, and history. This makes it important to distinguish it from conditions that can look similar on the skin. Common mimics include seborrheic dermatitis, psoriasis, contact dermatitis (both allergic and irritant), and fungal infections like ringworm. Each has features that help differentiate it, such as the greasy scale of seborrheic dermatitis or the well-demarcated silvery plaques of psoriasis.

Less common but more serious conditions can also present with eczema-like rashes. These include a type of skin lymphoma called mycosis fungoides, autoimmune diseases like dermatomyositis, nutritional deficiencies (particularly zinc and niacin), and certain genetic syndromes. Primary immunodeficiency disorders can also present with widespread eczema in infants and children. The takeaway is that persistent or unusual eczema, especially if it doesn’t respond to standard treatment, warrants a careful dermatologic evaluation to rule out these alternatives.

²⁴

Measuring Severity

If you’ve been treated at a dermatology clinic, you may have encountered the EASI score, one of the most widely used tools for grading how bad atopic dermatitis is. It evaluates the extent and intensity of eczema across four body regions and produces a score from 0 to 72. A score of zero means clear skin, while scores above about 21 indicate severe disease and scores above 50 are classified as very severe.

²⁵

These scores matter because treatment decisions and eligibility for biologic therapies often hinge on documented severity. They’re also used in clinical trials, so when you read that a drug produced a certain percentage improvement, it usually means improvement on the EASI or a similar scale. Knowing that the scale exists and roughly how it works can help you have more informed conversations with your dermatologist about where your disease falls and what treatment tier is appropriate.

Adult-Onset Atopic Dermatitis

It’s a common misconception that atopic dermatitis is exclusively a childhood disease. While it does typically start in the first few years of life, a meaningful number of people develop it for the first time as adults. This group looks different from the childhood-onset group in several ways: they tend to have fewer classic atopic features, fewer associated allergic conditions, and a weaker family history of eczema or asthma.

²

There may also be underlying biological differences. Research has shown that the immune profile in the skin of children with new-onset atopic dermatitis involves a broader set of inflammatory pathways than what’s typically seen in adults with long-standing disease.

⁶ Whether this translates into different treatment responses is an active area of research, but it does suggest that pediatric and adult atopic dermatitis may not be exactly the same disease wearing different clothing.²⁶